Edward Moler

Title: Edward Moler: Innovator in Cancer Research

Introduction

Edward Moler is a distinguished inventor based in Walnut Creek, CA (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 2 patents, Moler has focused on advancing methods for cancer diagnosis and treatment.

Latest Patents

Moler's latest patents include groundbreaking work on the effects of inhibitors of FGFR3 on gene transcription. This patent teaches methods of utilizing biomarkers to identify patients for treatment or to monitor their response to treatment. It emphasizes measuring alterations in levels of gene expression of the biomarkers, particularly in response to FGFR3 inhibition, allowing for necessary identifications or adjustments. Another notable patent is related to SEMA4D in cancer diagnosis, detection, and treatment. This invention pertains to methods for detecting cancer or the likelihood of developing cancer based on the presence or absence of the SEMA4D gene or proteins encoded by this gene. It also provides methods and molecules for upregulating or downregulating the SEMA4D gene.

Career Highlights

Throughout his career, Edward Moler has worked with prominent companies such as Novartis AG and Novartis Vaccines & Diagnostics GmbH. His experience in these organizations has contributed to his expertise in the field of cancer research and innovation.

Collaborations

Moler has collaborated with notable colleagues, including Michael Rowe and Carla C. Heise. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Edward Moler is a remarkable inventor whose work in cancer research has the potential to transform diagnosis and treatment methods. His innovative patents and collaborations highlight his commitment to advancing medical science.